Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14637409 | 0.87 | NR1H2 (0.42) | NR1H2KMT2AL3MBTL1CYP3A4KDM4E | |
| SCHEMBL9347752 | 0.86 | KMT2A (0.48) | NR1H2KMT2AL3MBTL1CYP3A4KDM4E | |
| SCHEMBL6739313 | 0.86 | KMT2A (0.48) | NR1H2TSHRKMT2AL3MBTL1CYP3A4 | |
| SCHEMBL25955768 | 0.84 | FKBP1A (0.52) | NR1H2TSHRKMT2AL3MBTL1CYP3A4 | |
| SCHEMBL23043376 | 0.81 | FKBP1A (0.53) | KMT2ACYP3A4KDM4EALDH1A1 | |
| SCHEMBL9347282 | 0.81 | FKBP1A (0.53) | KMT2ACYP3A4KDM4EALDH1A1 | |
| SCHEMBL12480874 | 0.80 | GRM6 (0.43) | TSHRKMT2AOPRK1 | |
| SCHEMBL29142190 | 0.80 | GRM6 (0.49) | TSHRKMT2AL3MBTL1ALDH1A1OPRK1 | |
| SCHEMBL4710674 | 0.80 | GRM6 (0.49) | TSHRKMT2AL3MBTL1ALDH1A1OPRK1 | |
| SCHEMBL4710677 | 0.80 | GRM6 (0.49) | TSHRKMT2AL3MBTL1ALDH1A1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023164680-A1 | 6-OXODECAHYDROPYRROLO[1,2-A][1,5]DIAZOCINE AND 6-OXODECAHYDRO-4H-PYRROLO[2,1-D][1,5]THIAZOCINE DERIVATIVES AS STAT3 AND STAT6 MODULATORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY CONDITIONS | RECLUDIX PHARMA, INC. (US) | 2023-08-31 | — | — | WO | disclosed |
| US-5342963-A | Optically active pyrrolidine derivative | AJINOMOTO CO., INC. (JP) | 1994-08-30 | — | — | US | disclosed |
| EP-0513398-A1 | INTERMEDIATE FOR SYNTHESIS OF CARBAPENEM AND PRODUCTION OF SAID INTERMEDIATE | Ajinomoto Co., Inc. (JP) | 1992-11-19 | — | — | EP | disclosed |